Organization
Yongchang Zhang
4 clinical trials
Clinical trial
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
Phase I/II Trial of Tumor Vaccine in Post Radical Operation Patients With Lung CancerStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Clinical trial
the Effectiveness and Safety Study on PD-1 Combined With Pyrotinib for First-line Chemotherapy Failed HER2 Insertion Mutation Advanced Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
A Phase II Study on Toripalimab Combined With Double Platinum Based Chemotherapy for as a Neoadjuvant Therapy for Potentially Resectable Non-driver Gene Mutation Non-small Cell Lung CancerStatus: Completed, Estimated PCD: 2022-06-30